Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant

Mayuko Kanayama, Emeline Colomba, Yusra Shao, Sarah M. Nielsen, Edward D. Esplin, Changxue Lu, William B. Isaacs, John C. Henegan, Elisabeth I. Heath, Jun Luo, Régine Marlin, Emmanuel S. Antonarakis

Research output: Contribution to journalArticlepeer-review

Abstract

Background: Recently, a germline HOXB13 variant, X285K was identified as a risk factor for prostate cancer in men of African ancestry. While this variant is likely associated with more aggressive prostate cancer, there has not yet been an in-depth clinical description of individual patients carrying this variant and their response to systemic therapies. Methods: We studied six cases of germline X285K carriers with metastatic hormone-sensitive prostate cancer to characterize their hormonal sensitivity or resistance. Conclusions: Longitudinal outcome analysis indicates that patients carrying X285K generally show favorable responses to therapies targeting the androgen receptor (AR), a finding that requires confirmation.

Original languageEnglish (US)
JournalProstate Cancer and Prostatic Diseases
DOIs
StateAccepted/In press - 2025

Bibliographical note

Publisher Copyright:
© The Author(s), under exclusive licence to Springer Nature Limited 2025.

PubMed: MeSH publication types

  • Journal Article

Fingerprint

Dive into the research topics of 'Case series exploring hormonal sensitivity in prostate cancer patients harboring the germline African-ancestry HOXB13 X285K variant'. Together they form a unique fingerprint.

Cite this